Vir Biotechnology Names Jason O’Byrne CFO
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
- Latest
- Trending
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
Cryptos rise despite outflows, BTC needs to maintain above $55,850 for stability, traders suggest.
UBS advises selling USD gains, citing medium-term weakness, while GBP shows potential for strength. CHF remains supported.
EU to lower tariffs on Tesla EVs to 7.8% from 9%, while other Chinese EV makers see slight adjustments in ...
Google faces another US antitrust lawsuit, focusing on its ad tech dominance, with potential for significant business impact.
Huntington adds corporate mortgage finance to enhance services for originators and servicers, led by industry veteran Ken Logan.
Explore AI's role in transforming healthcare, finance, transportation, and daily life with key benefits and challenges.
Strategist warns against high-risk investments amid volatility. Explore quality sectors for better returns.
VanEck's EFUT ETF will stop trading on Sept 16, 2024, and liquidate by Sept 23. Shareholders to receive cash distributions.
Explore the rising non-speculative use cases of blockchain and why they're gaining traction globally.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.